Project Details
Description
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic Stem Cell Transplantation
| Status | Finished |
|---|---|
| Effective start/end date | 4/15/12 → 5/1/17 |
Funding
- ALTOR BIOSCIENCE LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.